Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

Efficient 18F-Labeling of Synthetic Exendin-4 Analogues for Imaging Beta Cells.

Keliher EJ, Reiner T, Thurber GM, Upadhyay R, Weissleder R.

ChemistryOpen. 2012 Aug;1(4):177-183.

2.

18F-Tetrazine-trans-cyclooctene-Cys40-exendin-4.

Leung K.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2013 Feb 18 [updated 2013 Apr 25].

3.

N-(2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)ethyl)-4-[18F]-fluorobenzamide ([18F]FBEM) conjugated to EM3106B, an analog of glucagon-like peptide-1.

Chopra A.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2012 Feb 23 [updated 2012 Mar 22].

4.

N-2-(4-[18F]-Fluorobenzamido)ethylmaleimide coupled to cysteine-tagged on the C- or N-terminal of exendin-4.

Chopra A.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2012 Feb 21 [updated 2012 Mar 22].

5.

18F-radiolabeled GLP-1 analog exendin-4 for PET/CT imaging of insulinoma in small animals.

Wu H, Liang S, Liu S, Pan Y, Cheng D, Zhang Y.

Nucl Med Commun. 2013 Jul;34(7):701-8. doi: 10.1097/MNM.0b013e3283614187.

PMID:
23652208
6.

Development and evaluation of 18F-TTCO-Cys40-Exendin-4: a PET probe for imaging transplanted islets.

Wu Z, Liu S, Hassink M, Nair I, Park R, Li L, Todorov I, Fox JM, Li Z, Shively JE, Conti PS, Kandeel F.

J Nucl Med. 2013 Feb;54(2):244-51. doi: 10.2967/jnumed.112.109694. Epub 2013 Jan 7.

7.

68Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET.

Brom M, Oyen WJ, Joosten L, Gotthardt M, Boerman OC.

Eur J Nucl Med Mol Imaging. 2010 Jul;37(7):1345-55. doi: 10.1007/s00259-009-1363-y. Epub 2010 Jan 29.

8.

Preliminary evaluation of [18F]AlF-NOTA-MAL-Cys39-exendin-4 in insulinoma with PET.

Xu Q, Zhu C, Xu Y, Pan D, Liu P, Yang R, Wang L, Chen F, Sun X, Luo S, Yang M.

J Drug Target. 2015;23(9):813-20. doi: 10.3109/1061186X.2015.1020808. Epub 2015 Mar 11.

PMID:
25758750
9.

18F-radiolabeled analogs of exendin-4 for PET imaging of GLP-1 in insulinoma.

Kiesewetter DO, Gao H, Ma Y, Niu G, Quan Q, Guo N, Chen X.

Eur J Nucl Med Mol Imaging. 2012 Mar;39(3):463-73. doi: 10.1007/s00259-011-1980-0. Epub 2011 Dec 15.

10.

Non-invasive glucagon-like peptide-1 receptor imaging in pancreas with (18)F-Al labeled Cys(39)-exendin-4.

Mi B, Xu Y, Pan D, Wang L, Yang R, Yu C, Wan W, Wu Y, Yang M.

Biochem Biophys Res Commun. 2016 Feb 26;471(1):47-51. doi: 10.1016/j.bbrc.2016.01.184. Epub 2016 Feb 3.

PMID:
26850848
11.

[Lys40(Ahx-DTPA-111In)NH2]exendin-4, a very promising ligand for glucagon-like peptide-1 (GLP-1) receptor targeting.

Wild D, Béhé M, Wicki A, Storch D, Waser B, Gotthardt M, Keil B, Christofori G, Reubi JC, Mäcke HR.

J Nucl Med. 2006 Dec;47(12):2025-33.

12.

Low kidney uptake of GLP-1R-targeting, beta cell-specific PET tracer, 18F-labeled [Nle14,Lys40]exendin-4 analog, shows promise for clinical imaging.

Mikkola K, Yim CB, Lehtiniemi P, Kauhanen S, Tarkia M, Tolvanen T, Nuutila P, Solin O.

EJNMMI Res. 2016 Dec;6(1):91. Epub 2016 Dec 13.

13.

Development of 111In-labeled exendin(9-39) derivatives for single-photon emission computed tomography imaging of insulinoma.

Kimura H, Matsuda H, Ogawa Y, Fujimoto H, Toyoda K, Fujita N, Arimitsu K, Hamamatsu K, Yagi Y, Ono M, Inagaki N, Saji H.

Bioorg Med Chem. 2017 Feb 15;25(4):1406-1412. doi: 10.1016/j.bmc.2016.12.051. Epub 2017 Jan 3.

PMID:
28089587
14.

Development of 68Ga- and 89Zr-Labeled Exendin-4 as Potential Radiotracers for the Imaging of Insulinomas by PET.

Bauman A, Valverde IE, Fischer CA, Vomstein S, Mindt TL.

J Nucl Med. 2015 Oct;56(10):1569-74. doi: 10.2967/jnumed.115.159186. Epub 2015 Aug 6.

15.

Pre-clinical evaluation of [(68)Ga]Ga-DO3A-VS-Cys(40)-Exendin-4 for imaging of insulinoma.

Selvaraju RK, Velikyan I, Asplund V, Johansson L, Wu Z, Todorov I, Shively J, Kandeel F, Eriksson B, Korsgren O, Eriksson O.

Nucl Med Biol. 2014 Jul;41(6):471-6. doi: 10.1016/j.nucmedbio.2014.03.017. Epub 2014 Mar 29.

PMID:
24857864
16.

Exendin-4-based radiopharmaceuticals for glucagonlike peptide-1 receptor PET/CT and SPECT/CT.

Wild D, Wicki A, Mansi R, Béhé M, Keil B, Bernhardt P, Christofori G, Ell PJ, Mäcke HR.

J Nucl Med. 2010 Jul;51(7):1059-67. doi: 10.2967/jnumed.110.074914.

17.

Efficient 18F labeling of cysteine-containing peptides and proteins using tetrazine-trans-cyclooctene ligation.

Liu S, Hassink M, Selvaraj R, Yap LP, Park R, Wang H, Chen X, Fox JM, Li Z, Conti PS.

Mol Imaging. 2013 Mar-Apr;12(2):121-8.

18.

In vivo imaging of transplanted islets with 64Cu-DO3A-VS-Cys40-Exendin-4 by targeting GLP-1 receptor.

Wu Z, Todorov I, Li L, Bading JR, Li Z, Nair I, Ishiyama K, Colcher D, Conti PE, Fraser SE, Shively JE, Kandeel F.

Bioconjug Chem. 2011 Aug 17;22(8):1587-94. doi: 10.1021/bc200132t. Epub 2011 Jul 14.

PMID:
21692471
19.

GLP-1 and exendin-4 for imaging endocrine pancreas. A review. Labelled glucagon-like peptide-1 analogues: past, present and future.

Hubalewska-Dydejczyk A, Sowa-Staszczak A, Tomaszuk M, Stefańska A.

Q J Nucl Med Mol Imaging. 2015 Jun;59(2):152-60. Epub 2015 Feb 26. Review.

20.

PET of insulinoma using ¹⁸F-FBEM-EM3106B, a new GLP-1 analogue.

Gao H, Niu G, Yang M, Quan Q, Ma Y, Murage EN, Ahn JM, Kiesewetter DO, Chen X.

Mol Pharm. 2011 Oct 3;8(5):1775-82. doi: 10.1021/mp200141x. Epub 2011 Aug 19.

Supplemental Content

Support Center